FDA.reportPublic FDA data

Blemish Bully Acne Spot Treatment

Manufacturer
Tarte Inc.
Effective date
2018-03-27
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 00:47:39

Label at a glance#

ProductBlemish Bully Acne Spot Treatment
Active ingredientSalicylic acid
Label structure10 sections

Indications and uses

For the treatment of Acne. Helps keep skin clear of new acne blemishes, blackheads or whiteheads.

Dosage and administration

Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times a daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Storage and handling

You may report a serious adverse reaction to: tarte c/o Report Reaction, LLC, P.O. Box 22, Plainsboro, New Jersey 08536-0222.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 1.5%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses

INDICATIONS & USAGE SECTION

  • For the treatment of Acne.
  • Helps keep skin clear of new acne blemishes, blackheads or whiteheads.

Warnings

WARNINGS SECTION

For external use only.

Avoid eye and lip areas

When using this product

OTC - WHEN USING SECTION

  • Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Flammable, keep away from heat and flame.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Cover the entire affected area with a thin layer one to three times a daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other information

STORAGE AND HANDLING SECTION

  • You may report a serious adverse reaction to: tarte c/o Report Reaction, LLC, P.O. Box 22, Plainsboro, New Jersey 08536-0222.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, SD alcohol 40-B, butylene glycol, niacinamide, carbomer, octadecenedioic acid, phenoxyethanol, aminomethyl propanol, azelaic acid, caffeine, sodium ascorbyl phosphate, glycerin, hamamelis virginiana (witch hazel) extract, eugenia caryophyllus (clove) leaf oil, eugenol, cucumis sativus (cucumber) fruit extract, origanum vulgare leaf oil.

SPL UNCLASSIFIED SECTION

Dist. by tarte™, Inc. New York, NY 10018.

PRINCIPAL DISPLAY PANEL - 10 mL Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

tarte skincare
high-performance naturals™

BLEMISH BULLY

acne spot
treatment

Principal Display Panel - 10 mL Tube Carton
Principal Display Panel - 10 mL Tube Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51060-125-012024-12-23C16284748780-1f386c64a-0571-0266-e053-dadaa90a7c1aBlemish Bully Acne Spot Treatment
51060-125-012023-01-30C16284748780-1f386c64a-0571-0266-e053-dadaa90a7c1aBlemish Bully Acne Spot Treatment

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51060-12551060-125-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Name, UNII, Kind table
NameUNIIKind
Salicylic acidO414PZ4LPZACTIB
WATER059QF0KO0RIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
NIACINAMIDE25X51I8RD4IACT
CARBOXYPOLYMETHYLENE0A5MM307FCIACT
OCTADECENEDIOIC ACID565ZMT5QRGIACT
PHENOXYETHANOLHIE492ZZ3TIACT
AMINOMETHYLPROPANOLLU49E6626QIACT
AZELAIC ACIDF2VW3D43YTIACT
CAFFEINE3G6A5W338EIACT
SODIUM ASCORBYL PHOSPHATE836SJG51DRIACT
GLYCERINPDC6A3C0OXIACT
HAMAMELIS VIRGINIANA TOPUDA30A2JJYIACT
CLOVE LEAF OILVCA5491KVFIACT
EUGENOL3T8H1794QWIACT
CUCUMBERYY7C30VXJTIACT
OREGANO LEAF OIL7D0CGR40U1IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
603bdea0-ee6b-48c1-866b-c80a4fdee6d3ac6d16d0-6bb2-4b93-9640-c1df993665482024-12-19WarningsExact identifier
spl set id: ac6d16d0-6bb2-4b93-9640-c1df99366548

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.